T1Type1Cure
A diabetes education and community support setting.
Carolyn Rafieymehr / Wikimedia Commons / Public domain
Clinical Trials/June 30, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • French Prospective Multicentric Study in Real World — RECRUITING. Interventions: Omnipod 5. Locations: Angers, France | Besançon, France | Bobigny, France. The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life,...Source
  • Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose — RECRUITING, NA. Interventions: Control (CON), Missed Dose (MISS), Missed Dose + 15min walk (MISS+EX). Locations: Montreal, Quebec, Canada. People living with type 1 diabetes (PwT1D) are recommended to administer insulin...Source
  • Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF) — RECRUITING, NA. Interventions: Investigational Procedure. Locations: Jeddah, Mecca Region, Saudi Arabia | Abu Dhabi, United Arab Emirates. The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in...Source
  • Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody — RECRUITING, PHASE2. Interventions: ex vivo expanded CD4+CD25+CD127- regulatory T cells (Tregs), Anti-CD20 (rituximab), Placebo. Locations: Bialystok, Poland | Gdansk, Poland | Katowice, Poland. The main purpose of the s...Source
  • Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study — RECRUITING, NA. Interventions: GLITTER comprehensive management. Locations: Beijing, Beijing Municipality, China | Beijing, Beijing Municipality, China | Guangzhou, Guangdong, China. The GLITTER study is comprised of fo...Source
  • Effects of Ketosis on Brain Function in Patients With T1DM — RECRUITING, NA. Interventions: Very low carbohydrate diet, Standard carbohydrate diet. Locations: Boston, Massachusetts, United States. The scientific goal of this study is to examine the effects of a ketogenic diet on...Source
  • Immunotherapy with Autologous Tregs in T1DM — RECRUITING, PHASE1. Interventions: Ex vivo Expanded Human Autologous Regulatory T Cells, Routine Care. Locations: Nanjing, Jiangsu, China. Type 1 diabetes (T1D) is an autoimmune disease characterized by a progressive im...Source
  • Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM) — RECRUITING, NA. Interventions: Clinical Demo 2.0. Locations: Neuss, Nordrhein-Westfallen, Germany. This is a single-centre, multiple cohort, open study.Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.